NASDAQ:ABVX ABIVAX Société Anonyme (ABVX) Stock Price, News & Analysis $11.86 +0.04 (+0.34%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$11.62▼$12.3050-Day Range$11.82▼$14.3152-Week Range$7.99▼$17.02Volume57,230 shsAverage Volume83,146 shsMarket Capitalization$746.34 millionP/E RatioN/ADividend YieldN/APrice Target$34.20 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get ABIVAX Société Anonyme alerts: Email Address ABIVAX Société Anonyme MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.83 Rating ScoreUpside/Downside188.4% Upside$34.20 Price TargetShort InterestHealthy0.10% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.21Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($2.98) to ($2.90) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.88 out of 5 starsMedical Sector451st out of 936 stocksPharmaceutical Preparations Industry207th out of 436 stocks 3.4 Analyst's Opinion Consensus RatingABIVAX Société Anonyme has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageABIVAX Société Anonyme has only been the subject of 3 research reports in the past 90 days.Read more about ABIVAX Société Anonyme's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.10% of the float of ABIVAX Société Anonyme has been sold short.Short Interest Ratio / Days to CoverABIVAX Société Anonyme has a short interest ratio ("days to cover") of 1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in ABIVAX Société Anonyme has recently decreased by 37.35%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldABIVAX Société Anonyme does not currently pay a dividend.Dividend GrowthABIVAX Société Anonyme does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ABVX. Previous Next 2.9 News and Social Media Coverage News SentimentABIVAX Société Anonyme has a news sentiment score of 1.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for ABIVAX Société Anonyme this week, compared to 2 articles on an average week. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ABIVAX Société Anonyme insiders have not sold or bought any company stock.Percentage Held by Institutions47.91% of the stock of ABIVAX Société Anonyme is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about ABIVAX Société Anonyme's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for ABIVAX Société Anonyme are expected to grow in the coming year, from ($2.98) to ($2.90) per share.Price to Book Value per Share RatioABIVAX Société Anonyme has a P/B Ratio of 3.52. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Unstoppable Prosperity“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.You can find out what they are by clicking here now. About ABIVAX Société Anonyme Stock (NASDAQ:ABVX)ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to stablize the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis in adults. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.Read More ABVX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ABVX Stock News HeadlinesJuly 15, 2024 | globenewswire.comAbivax Provides Operational and Key Program UpdateJune 4, 2024 | globenewswire.comAbivax releases the results of its May 30, 2024 Ordinary and Extraordinary General MeetingJuly 27, 2024 | The Oxford Club (Ad)Don't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research... But today, the author of Get Rich with Dividends is feeling extra generous...April 10, 2024 | seekingalpha.comABIVAX Société Anonyme (AAVXF) Q4 2023 Earnings Call TranscriptApril 10, 2024 | seekingalpha.comABVX ABIVAX Société AnonymeApril 2, 2024 | globenewswire.comAbivax reports 2023 financial results and operational updateMarch 14, 2024 | morningstar.comAbivax SA ADR ABVXFebruary 23, 2024 | wsj.comAbivax S.A. ADRJuly 27, 2024 | The Oxford Club (Ad)Don't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research... But today, the author of Get Rich with Dividends is feeling extra generous...February 20, 2024 | finance.yahoo.comABIVAX Société Anonyme (ABVX.PA)February 17, 2024 | morningstar.comAbivax SA ABVXFebruary 13, 2024 | finance.yahoo.comAbivax Announces Presentation of Four Abstracts for Obefazimod in Ulcerative Colitis and Sponsorship of Scientific Symposium at The 19th Congress of European Crohn’s and Colitis Organization (ECCO)January 29, 2024 | finance.yahoo.comAbivax Announces the Start of the Roadshow for its Proposed Global Offering and Proposed Nasdaq ListingJanuary 29, 2024 | finance.yahoo.comAbivax Announces the Filing of an Amended Registration Statement, Including an Estimated Initial Public Offering Price RangeJanuary 29, 2024 | finance.yahoo.comAbivax Announces Temporary Trading Halt of its Ordinary Shares on Euronext ParisJanuary 29, 2024 | finance.yahoo.comAbivax Announces the Pricing of its Initial Public Offering on the Nasdaq Global MarketJanuary 29, 2024 | finance.yahoo.comAbivax Announces Trading Resumption of its Ordinary Shares on Euronext ParisJanuary 29, 2024 | finance.yahoo.comAbivax Announces Closing of its Initial Public Offering on the Nasdaq Global MarketSee More Headlines Receive ABVX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ABIVAX Société Anonyme and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:ABVX Previous SymbolNASDAQ:ABVX CUSIPN/A CIK1956827 Webwww.abivax.com Phone33-1-53-83-09-63FaxN/AEmployees61Year FoundedN/APrice Target and Rating Average Stock Price Target$34.20 High Stock Price Target$50.00 Low Stock Price Target$16.00 Potential Upside/Downside+188.4%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.23 Current Ratio4.08 Quick Ratio4.08 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$3.37 per share Price / Book3.52Miscellaneous Outstanding Shares62,929,000Free FloatN/AMarket Cap$746.34 million OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Marc M. P. de Garidel M.B.A. (Age 66)CEO & Interim Chair of Board Comp: $862.25kDr. Philippe Pouletty M.D. (Age 66)Ph.D., Founder & Director Mr. Didier Blondel (Age 60)EVP, CFO & Board Secretary Mr. Didier Scherrer Ph.D. (Age 54)Chief Scientific Officer Mr. Patrick MalloySenior Vice President of Investor RelationsMs. Ida Hatoum (Age 49)Chief People Officer Mr. Pierre Courteille M.B.A. (Age 55)Chief Business Officer Mr. Jerome Denis Ph.D.Executive Vice President of Process Development & ManufacturingMr. Sheldon Sloan M.B.E. (Age 65)M.D., Chief Medical Officer Mr. Michael Ferguson B.S. (Age 46)M.B.A., Chief Commercial Officer More ExecutivesKey CompetitorsMoonLake ImmunotherapeuticsNASDAQ:MLTXApogee TherapeuticsNASDAQ:APGEMorphicNASDAQ:MORFMorphoSysNASDAQ:MORSpringWorks TherapeuticsNASDAQ:SWTXView All CompetitorsInstitutional OwnershipBlackstone Inc.Sold 251,112 shares on 5/16/2024Ownership: 3.365%Janus Henderson Group PLCBought 131,414 shares on 5/16/2024Ownership: 1.354%Kennedy Capital Management LLCBought 31,331 shares on 5/16/2024Ownership: 0.191%Sandia Investment Management LPSold 9,629 shares on 5/15/2024Ownership: 0.016%Capstone Investment Advisors LLCBought 5,199 shares on 5/1/2024Ownership: 0.100%View All Institutional Transactions ABVX Stock Analysis - Frequently Asked Questions How have ABVX shares performed this year? ABIVAX Société Anonyme's stock was trading at $10.70 on January 1st, 2024. Since then, ABVX stock has increased by 10.8% and is now trading at $11.86. View the best growth stocks for 2024 here. When did ABIVAX Société Anonyme IPO? ABIVAX Société Anonyme (ABVX) raised $217 million in an initial public offering (IPO) on Friday, October 20th 2023. The company issued 18,699,460 shares at $11.60 per share. How do I buy shares of ABIVAX Société Anonyme? Shares of ABVX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ABVX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredThe asset beating inflation by 4xCentral Bank Gold Heist In Progress Central banks are buying gold at record rates... and billionaire invest...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ABIVAX Société Anonyme Please log in to your account or sign up in order to add this asset to your watchlist. Share ABIVAX Société Anonyme With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ABVX Stock Alerts